Format

Send to

Choose Destination
Antivir Ther. 2015;20(8):855-63. doi: 10.3851/IMP2963. Epub 2015 Apr 23.

How often does treatment of primary HIV lead to post-treatment control?

Author information

1
Department of Medicine, University of Washington, Seattle, WA, USA. janine@u.washington.edu.

Abstract

BACKGROUND:

Post-treatment control of viraemia after discontinuation of antiretroviral therapy begun during primary HIV-1 infection is considered a potential path toward a sustained remission of infection.

METHODS:

Subjects enrolled in an observational primary infection cohort who received at least 11 months of highly active antiretroviral therapy beginning within the first 12 weeks of HIV-1 infection and who subsequently discontinued therapy were evaluated for post-treatment control.

RESULTS:

Within a cohort of 389 subjects with primary HIV-1 infection enrolled over 22 years, only 22 met criteria for evaluation of post-treatment control. Among these subjects, 21 (95%) had loss of viral control (HIV-1 RNA>500 copies/ml) within 18 months after treatment discontinuation, and only 1 (4.5%, 95% CI 0.32, 18.9) controlled viral load to levels <500 copies/ml for at least 24 months. The median time to virological failure was 2.17 (IQR 1.18-3.39) months.

CONCLUSIONS:

Our data suggest a low likelihood of post-treatment control even when highly active antiretroviral therapy is started within 12 weeks of HIV-1 infection.

PMID:
25906138
PMCID:
PMC5737758
DOI:
10.3851/IMP2963
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center